These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14514145)

  • 1. Contribution of efflux to cefuroxime resistance in clinical isolates of Escherichia coli.
    Källman O; Fendukly F; Karlsson I; Kronvall G
    Scand J Infect Dis; 2003; 35(8):464-70. PubMed ID: 14514145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefuroxime resistance in Escherichia coli. Resistance mechanisms and prevalence.
    Schumacher H; Skibsted U; Skov R; Scheibel J
    APMIS; 1996; 104(7-8):531-8. PubMed ID: 8920806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefuroxime resistance in Klebsiella pneumoniae. Susceptibility to cefotaxime and ceftazidime despite production of ESBLs.
    Schumacher H; Skibsted U; Hansen DS; Scheibel J
    APMIS; 1997 Sep; 105(9):708-16. PubMed ID: 9350215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions.
    Oteo J; Navarro C; Cercenado E; Delgado-Iribarren A; Wilhelmi I; Orden B; García C; Miguelañez S; Pérez-Vázquez M; García-Cobos S; Aracil B; Bautista V; Campos J
    J Clin Microbiol; 2006 Jul; 44(7):2359-66. PubMed ID: 16825350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of efflux, impermeability, and AmpC activity contributes to cefuroxime resistance in clinical, non-ESBL-producing isolates of Escherichia coli.
    Källman O; Giske CG; Samuelsen Ø; Wretlind B; Kalin M; Olsson-Liljequist B
    Microb Drug Resist; 2009 Jun; 15(2):91-5. PubMed ID: 19432520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum beta-lactamases in Escherichia coli and Klebsiella spp. in European septicaemia isolates.
    Pörnull KJ; Göransson E; Rytting AS; Dornbusch K
    J Antimicrob Chemother; 1993 Oct; 32(4):559-70. PubMed ID: 8288497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression levels of chromosomal AmpC β-lactamase in clinical Escherichia coli isolates and their effect on susceptibility to extended-spectrum cephalosporins.
    Paltansing S; Kraakman M; van Boxtel R; Kors I; Wessels E; Goessens W; Tommassen J; Bernards A
    Microb Drug Resist; 2015 Feb; 21(1):7-16. PubMed ID: 25188329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of susceptibility of bacteria isolated from clinical material to cefuroxime, ceftazidime and cefotaxime].
    Giedrys-Kalemba S; Bilska I
    Med Dosw Mikrobiol; 1993; 45(2):173-6. PubMed ID: 8309292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative contribution of efflux to multi-drug resistance of clinical Escherichia coli and Pseudomonas aeruginosa strains.
    Cunrath O; Meinel DM; Maturana P; Fanous J; Buyck JM; Saint Auguste P; Seth-Smith HMB; Körner J; Dehio C; Trebosc V; Kemmer C; Neher R; Egli A; Bumann D
    EBioMedicine; 2019 Mar; 41():479-487. PubMed ID: 30852163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical isolates of Escherichia coli are resistant both to antibiotics and organotin compounds.
    Aguilar-Santelises M; Castillo-Vera J; Gonzalez-Molina R; Garcia Del Valle A; Cruz Millan M; Aguilar-Santelises L
    Folia Microbiol (Praha); 2020 Feb; 65(1):87-94. PubMed ID: 31001763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ampicillin versus cefuroxime on the emergence of beta-lactam resistance in faecal Enterobacter cloacae isolates from neonates.
    Burman LG; Berglund B; Huovinen P; Tullus K
    J Antimicrob Chemother; 1993 Jan; 31(1):111-6. PubMed ID: 8444655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
    Abrar S; Vajeeha A; Ul-Ain N; Riaz S
    Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predominant β-lactamase genotypes of Escherichia coli isolates and induction and inhibition mechanisms of β-lactamase gene expression].
    Tan P; Wang Z; Sun A; Yan J; Zhao J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):484-90. PubMed ID: 26080639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of various beta-lactam antibiotics and phenotypical methods for detection of TEM, SHV and CTX-M extended-spectrum beta-lactamases.
    Bedenic B; Vranes J; Mihaljevic Lj; Tonkic M; Sviben M; Plecko V; Kalenic S
    J Chemother; 2007 Apr; 19(2):127-39. PubMed ID: 17434820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes of antimicrobial resistance among clinical isolates of Escherichia coil in Shanghai 1990-2004].
    Zhang YY; Zhu DM; Hu FP; Wu S; Wang F
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):12-6. PubMed ID: 16606528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of cross-resistance to beta-lactam antibiotics in fecal Escherichia coli and Klebsiella strains from neonates treated with ampicillin or cefuroxime.
    Tullus K; Berglund B; Burman LG
    Antimicrob Agents Chemother; 1990 Feb; 34(2):361-2. PubMed ID: 2183720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of eight different cephalosporins for detection of cephalosporin resistance in Salmonella enterica and Escherichia coli.
    Aarestrup FM; Hasman H; Veldman K; Mevius D
    Microb Drug Resist; 2010 Dec; 16(4):253-61. PubMed ID: 20624078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.